| RS10757274 |
CDKN2B-AS1
|
Health Risk |
risk factor |
Three Vessel Coronary Disease, Three Vessel Coronary Disease |
| RS10759497 |
ECPAS
|
Health Risk |
association |
Vascular endothelial growth factor (VEGF) inhibitor response, Vascular endothelial growth factor (VEGF) inhibitor response |
| RS1076466 |
PRODH
|
Health Risk |
Conflicting classifications of pathogenicity |
Proline dehydrogenase deficiency, Schizophrenia 4 |
| RS10776 |
BSCL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital generalized lipodystrophy type 2, Neuronopathy |
| RS10789501 |
CYP4A22
|
Health Risk |
association |
Pulmonary disease, chronic obstructive |
| RS10835638 |
FSHB
|
Health Risk |
association |
Hypogonadotropic hypogonadism 24 without anosmia, Hypogonadotropic hypogonadism 24 without anosmia |
| RS10836312 |
-
|
Health Risk |
association |
Chronic obstructive pulmonary disease, Chronic obstructive pulmonary disease |
| RS1085307049 |
CLRN1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 3, Retinitis pigmentosa 61 |
| RS1085307051 |
MEF2C
|
Health Risk |
Likely pathogenic |
Frontotemporal dementia, Frontotemporal dementia |
| RS1085307053 |
COQ8A
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS1085307054 |
ALMS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1085307056 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS1085307057 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Wilson disease |
| RS1085307058 |
BCKDHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1085307066 |
FBN2
|
Health Risk |
Likely pathogenic |
Congenital contractural arachnodactyly, Congenital contractural arachnodactyly |
| RS1085307068 |
GORAB
|
Health Risk |
Pathogenic/Likely pathogenic |
Geroderma osteodysplastica, Geroderma osteodysplastica |
| RS1085307072 |
HSD17B4
|
Health Risk |
Likely pathogenic |
Perrault syndrome 1, Bifunctional peroxisomal enzyme deficiency |
| RS1085307074 |
IFT140
|
Health Risk |
Likely pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS1085307078 |
LRP5
|
Health Risk |
Pathogenic/Likely pathogenic |
Bone mineral density quantitative trait locus 1, 6 conditions |
| RS1085307081 |
NCSTN
|
Health Risk |
Pathogenic |
Acne inversa, familial |
| RS1085307083 |
ORC4
|
Health Risk |
Pathogenic |
Meier-Gorlin syndrome 2, Meier-Gorlin syndrome 2 |
| RS1085307087 |
PPT1
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS1085307088 |
RAD50
|
Health Risk |
Conflicting classifications of pathogenicity |
Nijmegen breakage syndrome-like disorder, Hereditary cancer-predisposing syndrome |
| RS1085307090 |
RECQL4
|
Health Risk |
Likely pathogenic |
Baller-Gerold syndrome, Rothmund-Thomson syndrome |
| RS1085307091 |
RNASEH2B
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 2, Aicardi-Goutieres syndrome 2 |
| RS1085307095 |
SLC7A9
|
Health Risk |
Likely pathogenic |
Cystinuria, Cystinuria |
| RS1085307096 |
SLCO2A1
|
Health Risk |
Likely pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS1085307097 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1085307100 |
TRDN
|
Health Risk |
Pathogenic/Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 5, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1085307101 |
TRIP11
|
Health Risk |
Likely pathogenic |
Achondrogenesis, type IA |
| RS1085307107 |
SUMF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple sulfatase deficiency, Multiple sulfatase deficiency |
| RS1085307108 |
ZBTB18
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS1085307109 |
ZBTB18
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS1085307110 |
KY
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia, Hereditary spastic paraplegia |
| RS1085307111 |
ACP4
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, type 1J |
| RS1085307112 |
HGSNAT
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-C |
| RS1085307113 |
MTOR
|
Health Risk |
Pathogenic |
Isolated focal cortical dysplasia type II, CEBALID syndrome |
| RS1085307114 |
MTOR
|
Health Risk |
Pathogenic |
Isolated focal cortical dysplasia type II, Isolated focal cortical dysplasia type II |
| RS1085307115 |
RPS27
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 17, Diamond-Blackfan anemia 17 |
| RS1085307118 |
USP18
|
Health Risk |
Likely pathogenic |
Pseudo-TORCH syndrome 2, Pseudo-TORCH syndrome 2 |
| RS1085307119 |
RPL27
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 16, Diamond-Blackfan anemia 16 |
| RS1085307120 |
CEP135
|
Health Risk |
Pathogenic |
Microcephaly 8, primary |
| RS1085307121 |
CFAP418
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 16, Cone-rod dystrophy 16 |
| RS1085307122 |
SMAD6
|
Health Risk |
risk factor |
CRANIOSYNOSTOSIS 7, SUSCEPTIBILITY TO |
| RS1085307124 |
NECTIN4
|
Health Risk |
Pathogenic |
Ectodermal dysplasia-syndactyly syndrome 1, Ectodermal dysplasia-syndactyly syndrome 1 |
| RS1085307125 |
NECTIN4
|
Health Risk |
Pathogenic |
Ectodermal dysplasia-syndactyly syndrome 1, Ectodermal dysplasia-syndactyly syndrome 1 |
| RS1085307126 |
BFSP1
|
Health Risk |
Pathogenic |
Cataract 33, Cataract 33 |
| RS1085307127 |
BFSP1
|
Health Risk |
Pathogenic |
Cataract 33, Cataract 33 |
| RS1085307128 |
RAB33B
|
Health Risk |
Pathogenic |
Smith-McCort dysplasia 2, Smith-McCort dysplasia 2 |
| RS1085307129 |
RAB33B
|
Health Risk |
Conflicting classifications of pathogenicity |
Smith-McCort dysplasia 2, Smith-McCort dysplasia 2 |
| RS1085307130 |
RAB33B
|
Health Risk |
Pathogenic |
Smith-McCort dysplasia 2, Smith-McCort dysplasia 2 |
| RS1085307131 |
RAB33B
|
Health Risk |
Pathogenic |
Smith-McCort dysplasia 2, Smith-McCort dysplasia 2 |
| RS1085307132 |
PUF60
|
Health Risk |
Likely pathogenic |
— |
| RS1085307134 |
PUF60
|
Health Risk |
Likely pathogenic |
— |
| RS1085307135 |
PUF60
|
Health Risk |
Pathogenic/Likely pathogenic |
8q24.3 microdeletion syndrome, Inborn genetic diseases |
| RS1085307137 |
PUF60
|
Health Risk |
Pathogenic/Likely pathogenic |
8q24.3 microdeletion syndrome, 8q24.3 microdeletion syndrome |
| RS1085307138 |
PUF60
|
Health Risk |
Likely pathogenic |
— |
| RS1085307139 |
PUF60
|
Health Risk |
Likely pathogenic |
— |
| RS1085307142 |
SCN11A
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 7, Hereditary sensory and autonomic neuropathy type 7 |
| RS1085307143 |
SALL1
|
Health Risk |
Pathogenic |
Townes-Brocks syndrome 1, Townes-Brocks syndrome 1 |
| RS1085307144 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307145 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307146 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307147 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307148 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307149 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307150 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307151 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307152 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307153 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307154 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307155 |
BMPR2
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, primary |
| RS1085307156 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307157 |
BMPR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary hypertension, primary |
| RS1085307158 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307159 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307160 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307161 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307162 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307163 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307164 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307165 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307166 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307169 |
BMPR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary hypertension, primary |
| RS1085307170 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307171 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307172 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307173 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307174 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307175 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307176 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307177 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307178 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307179 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307180 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307181 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307182 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1085307183 |
BMPR2
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, primary |
| RS1085307184 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary arterial hypertension, Pulmonary hypertension |
| RS1085307185 |
BMPR2
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |